Cargando…

Impact of the Sensitivity to Empiric Antibiotics on Clinical Outcomes after Biliary Drainage for Acute Cholangitis

BACKGROUND/AIMS: Empiric antibiotics are given in combination with biliary drainage for acute cholangitis but sometimes turn out to be insensitive to microorganisms in blood and bile. Clinical outcomes were compared according to sensitivity to microorganisms detected in blood and bile culture to eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawamura, Satoshi, Karasawa, Yuki, Toda, Nobuo, Nakai, Yousuke, Shibata, Chikako, Kurokawa, Ken, Arai, Junya, Funato, Kazuyoshi, Kurosaki, Shigeyuki, Maeshima, Shuya, Kondo, Mayuko, Kojima, Kentaro, Ohki, Takamasa, Seki, Michiharu, Koike, Kazuhiko, Tagawa, Kazumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667925/
https://www.ncbi.nlm.nih.gov/pubmed/32050314
http://dx.doi.org/10.5009/gnl19248
_version_ 1783610404064198656
author Kawamura, Satoshi
Karasawa, Yuki
Toda, Nobuo
Nakai, Yousuke
Shibata, Chikako
Kurokawa, Ken
Arai, Junya
Funato, Kazuyoshi
Kurosaki, Shigeyuki
Maeshima, Shuya
Kondo, Mayuko
Kojima, Kentaro
Ohki, Takamasa
Seki, Michiharu
Koike, Kazuhiko
Tagawa, Kazumi
author_facet Kawamura, Satoshi
Karasawa, Yuki
Toda, Nobuo
Nakai, Yousuke
Shibata, Chikako
Kurokawa, Ken
Arai, Junya
Funato, Kazuyoshi
Kurosaki, Shigeyuki
Maeshima, Shuya
Kondo, Mayuko
Kojima, Kentaro
Ohki, Takamasa
Seki, Michiharu
Koike, Kazuhiko
Tagawa, Kazumi
author_sort Kawamura, Satoshi
collection PubMed
description BACKGROUND/AIMS: Empiric antibiotics are given in combination with biliary drainage for acute cholangitis but sometimes turn out to be insensitive to microorganisms in blood and bile. Clinical outcomes were compared according to sensitivity to microorganisms detected in blood and bile culture to evaluate the impact of sensitivity to empiric antibiotics in cholangitis. METHODS: Consecutive patients who underwent biliary drainage for acute cholangitis were retrospectively studied. Clinical outcomes such as 30-day mortality, length of hospital stay and high care unit stay, organ dysfunction and duration of fever were compared in three groups group A (sensitive to both blood and bile culture), group B (sensitive to blood culture alone) and group C (insensitive to both blood and bile culture). RESULTS: Eighty episodes of cholangitis were classified according to sensitivity results 42, 32 and six in groups A, B and C. Escherichia coli and Klebsiella were two major pathogens. There were no significant differences in 30-day mortality rate (7%, 0%, and 0%, p=0.244), length of hospital stay (28.5, 21.0, and 20.5 days, p=0.369), organ dysfunction rate (14%, 25%, and 17%, p=0.500), duration of fever (4.3, 3.2, and 3.5 days, p=0.921) and length of high care unit stay (1.4, 1.2, and 1.7 days, p=0.070) in groups A, B and C. Empiric antibiotics were changed in 11 episodes but clinical outcomes appeared to be non-inferior even in 31 episodes of cholangitis who were on inadequate antibiotics throughout the course. CONCLUSIONS: Sensitivity of empiric antibiotics was not associated with clinical outcomes in acute cholangitis.
format Online
Article
Text
id pubmed-7667925
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Editorial Office of Gut and Liver
record_format MEDLINE/PubMed
spelling pubmed-76679252020-11-18 Impact of the Sensitivity to Empiric Antibiotics on Clinical Outcomes after Biliary Drainage for Acute Cholangitis Kawamura, Satoshi Karasawa, Yuki Toda, Nobuo Nakai, Yousuke Shibata, Chikako Kurokawa, Ken Arai, Junya Funato, Kazuyoshi Kurosaki, Shigeyuki Maeshima, Shuya Kondo, Mayuko Kojima, Kentaro Ohki, Takamasa Seki, Michiharu Koike, Kazuhiko Tagawa, Kazumi Gut Liver Original Article BACKGROUND/AIMS: Empiric antibiotics are given in combination with biliary drainage for acute cholangitis but sometimes turn out to be insensitive to microorganisms in blood and bile. Clinical outcomes were compared according to sensitivity to microorganisms detected in blood and bile culture to evaluate the impact of sensitivity to empiric antibiotics in cholangitis. METHODS: Consecutive patients who underwent biliary drainage for acute cholangitis were retrospectively studied. Clinical outcomes such as 30-day mortality, length of hospital stay and high care unit stay, organ dysfunction and duration of fever were compared in three groups group A (sensitive to both blood and bile culture), group B (sensitive to blood culture alone) and group C (insensitive to both blood and bile culture). RESULTS: Eighty episodes of cholangitis were classified according to sensitivity results 42, 32 and six in groups A, B and C. Escherichia coli and Klebsiella were two major pathogens. There were no significant differences in 30-day mortality rate (7%, 0%, and 0%, p=0.244), length of hospital stay (28.5, 21.0, and 20.5 days, p=0.369), organ dysfunction rate (14%, 25%, and 17%, p=0.500), duration of fever (4.3, 3.2, and 3.5 days, p=0.921) and length of high care unit stay (1.4, 1.2, and 1.7 days, p=0.070) in groups A, B and C. Empiric antibiotics were changed in 11 episodes but clinical outcomes appeared to be non-inferior even in 31 episodes of cholangitis who were on inadequate antibiotics throughout the course. CONCLUSIONS: Sensitivity of empiric antibiotics was not associated with clinical outcomes in acute cholangitis. Editorial Office of Gut and Liver 2020-11-15 2020-02-14 /pmc/articles/PMC7667925/ /pubmed/32050314 http://dx.doi.org/10.5009/gnl19248 Text en Copyright © 2020 by The Korean Society of Gastroenterology, the Korean Society of Gastrointestinal Endoscopy, the Korean Society of Neurogastroenterology and Motility, Korean College of Helicobacter and Upper Gastrointestinal Research, Korean Association the Study of Intestinal Diseases, the Korean Association for the Study of the Liver, Korean Pancreatobiliary Association, and Korean Society of Gastrointestinal Cancer. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kawamura, Satoshi
Karasawa, Yuki
Toda, Nobuo
Nakai, Yousuke
Shibata, Chikako
Kurokawa, Ken
Arai, Junya
Funato, Kazuyoshi
Kurosaki, Shigeyuki
Maeshima, Shuya
Kondo, Mayuko
Kojima, Kentaro
Ohki, Takamasa
Seki, Michiharu
Koike, Kazuhiko
Tagawa, Kazumi
Impact of the Sensitivity to Empiric Antibiotics on Clinical Outcomes after Biliary Drainage for Acute Cholangitis
title Impact of the Sensitivity to Empiric Antibiotics on Clinical Outcomes after Biliary Drainage for Acute Cholangitis
title_full Impact of the Sensitivity to Empiric Antibiotics on Clinical Outcomes after Biliary Drainage for Acute Cholangitis
title_fullStr Impact of the Sensitivity to Empiric Antibiotics on Clinical Outcomes after Biliary Drainage for Acute Cholangitis
title_full_unstemmed Impact of the Sensitivity to Empiric Antibiotics on Clinical Outcomes after Biliary Drainage for Acute Cholangitis
title_short Impact of the Sensitivity to Empiric Antibiotics on Clinical Outcomes after Biliary Drainage for Acute Cholangitis
title_sort impact of the sensitivity to empiric antibiotics on clinical outcomes after biliary drainage for acute cholangitis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667925/
https://www.ncbi.nlm.nih.gov/pubmed/32050314
http://dx.doi.org/10.5009/gnl19248
work_keys_str_mv AT kawamurasatoshi impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis
AT karasawayuki impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis
AT todanobuo impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis
AT nakaiyousuke impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis
AT shibatachikako impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis
AT kurokawaken impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis
AT araijunya impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis
AT funatokazuyoshi impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis
AT kurosakishigeyuki impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis
AT maeshimashuya impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis
AT kondomayuko impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis
AT kojimakentaro impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis
AT ohkitakamasa impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis
AT sekimichiharu impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis
AT koikekazuhiko impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis
AT tagawakazumi impactofthesensitivitytoempiricantibioticsonclinicaloutcomesafterbiliarydrainageforacutecholangitis